Literature DB >> 10879777

Minimally invasive retroperitoneal approach for lumbar corpectomy and anterior reconstruction. Technical note.

M Mühlbauer1, W Pfisterer, R Eyb, E Knosp.   

Abstract

The anterior decompressive procedure in which spinal fusion is performed is considered an effective treatment for thoracolumbar fractures and tumors. However, it is also known to be associated with considerable surgery-related trauma. The purpose of this study was to show that lumbar corpectomy and anterior reconstruction can be performed via a minimally invasive retroperitoneal approach (MIRA) and therefore the surgical approach-related trauma can be reduced. The authors studied retrospectively the hospital records and radiological studies obtained in five patients (mean age 67.4 years, range 59-76 years) who underwent lumbar corpectomy and spinal fusion via an MIRA followed by posterior fixation. Four patients presented with osteoporotic compression fractures at L-2 and L-3, and one patient presented with metastatic disease in L-4 from prostate cancer. Neurological deficits due to cauda equina compression were demonstrated in all patients. The MIRA provided excellent exposure to facilitate complete decompression and anterior reconstruction in all patients, as verified on follow-up radiographic studies. All patients improved clinically. A 1-year follow-up record is available for four patients and a 6-month follow-up record for the fifth patient; continuing clinical improvement has been observed in all. Radiography demonstrated anatomically correct reconstruction in all patients, as well as a solid fusion or a stable compound union in the four patients for whom 1-year follow-up records were available. The MIRA allows the surgeon to perform anterior lumbar spine surgery via a less invasive approach. The efficacy and safety of this technique and its potential to reduce perioperative morbidity compared with conventional retroperitoneal lumbar spine surgery should be further investigated in a larger series.

Entities:  

Mesh:

Year:  2000        PMID: 10879777     DOI: 10.3171/spi.2000.93.1.0161

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Circumferential stabilization with ghost screwing after posterior resection of spinal metastases via transpedicular route.

Authors:  Alparslan Senel; Ahmet Hilmi Kaya; Enis Kuruoglu; Fahrettin Celik
Journal:  Neurosurg Rev       Date:  2007-02-24       Impact factor: 3.042

2.  Spinal shortening and monosegmental posterior spondylodesis in the management of dorsal and lumbar unstable injuries.

Authors:  Tarek A Aly
Journal:  J Neurosci Rural Pract       Date:  2011-01

3.  A systematic review of the current role of minimally invasive spine surgery in the management of metastatic spine disease.

Authors:  Camilo A Molina; Ziya L Gokaslan; Daniel M Sciubba
Journal:  Int J Surg Oncol       Date:  2011-06-02

4.  Minimally Invasive Pedicle Screw Fixation Combined with Percutaneous Kyphoplasty Under O-Arm Navigation for the Treatment of Metastatic Spinal Tumors with Posterior Wall Destruction.

Authors:  Zhang-Zhe Zhou; Yi-Meng Wang; Xiao Liang; Xiao Ze; Hao Liu; Kang-Wu Chen; Xiao-Yu Zhu; Zhi-Yong Sun; Zhong-Lai Qian
Journal:  Orthop Surg       Date:  2020-06-23       Impact factor: 2.071

5.  Technical nuances and approach-related morbidity of anterolateral and posterolateral lumbar corpectomy approaches-a systematic review of the literature.

Authors:  Christoph Wipplinger; Sara Lener; Christoph Orban; Tamara M Wipplinger; Anto Abramovic; Anna Lang; Sebastian Hartmann; Claudius Thomé
Journal:  Acta Neurochir (Wien)       Date:  2022-06-11       Impact factor: 2.816

Review 6.  When Less Is More: The indications for MIS Techniques and Separation Surgery in Metastatic Spine Disease.

Authors:  Scott L Zuckerman; Ilya Laufer; Arjun Sahgal; Yoshiya J Yamada; Meic H Schmidt; Dean Chou; John H Shin; Naresh Kumar; Daniel M Sciubba
Journal:  Spine (Phila Pa 1976)       Date:  2016-10-15       Impact factor: 3.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.